Bioxytran (BIXT) Operating Income (2010 - 2026)
Bioxytran's Operating Income was -$654,600 in Q2 2026, compared with -$224,077 a year earlier.
Powered by 
Analysis
Bioxytran (BIXT) Operating Income (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Bioxytran's Operating Income was -$3.69 million through Jun 30, 2026; for FY2025, it was -$1.84 million.
- In earlier years, Operating Income was -$2.22 million in FY2024, -$3.8 million in FY2023, -$2.44 million in FY2022 and -$4.21 million in FY2021.
- Quarterly Operating Income has moved between -$1.93 million (Q1 2026) and $14,225 (Q3 2022) over five years.
- Per Business Quant data, BIXT's Operating Income in the three quarters before Q2 2026 was -$1.93 million (Q1 2026), -$607,285 (Q4 2025) and -$496,005 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 11.75 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 7.14 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 6.43 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | -584.00 Mn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 4.75 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 3.16 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 3.51 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | -10.39 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 4.27 Bn |
| 10 | Bioxytran | 2.29 Mn | 1.13 Mn | - | -654,600.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -654,600.00 |
| Mar 31, 2026 | -1.93 Mn |
| Dec 31, 2025 | -607,285.00 |
| Sep 30, 2025 | -496,005.00 |
| Jun 30, 2025 | -224,077.00 |
| Mar 31, 2025 | -515,142.00 |
| Dec 31, 2024 | -488,313.00 |
| Sep 30, 2024 | -346,204.00 |
| Jun 30, 2024 | -609,322.00 |
| Mar 31, 2024 | -779,229.00 |
| Dec 31, 2023 | -1.01 Mn |
| Sep 30, 2023 | -985,465.00 |
| Jun 30, 2023 | -1.06 Mn |
| Mar 31, 2023 | -750,242.00 |
| Dec 31, 2022 | -1.09 Mn |
| Sep 30, 2022 | 14,225.00 |
| Jun 30, 2022 | -537,224.00 |
| Mar 31, 2022 | -819,106.00 |
| Dec 31, 2021 | -935,964.00 |
| Sep 30, 2021 | -547,243.00 |
API Access
Bioxytran Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-income&ticker=BIXT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-income", "ticker": "BIXT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-income&ticker=BIXT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();